AGO2’s RISC activity and miRNA duplex unwinding were inhibited by interaction with mutant KRAS (9), suggesting that the RAS–AGO2 interaction plays a dynamic role in promoting mutant KRAS-driven cancer. The gene discussed is KRAS; the disease is cancer.